首页 > 最新文献

Ulusal cerrahi dergisi最新文献

英文 中文
Recurrent pilonidal disease surgery: Is it second primary or reoperative surgery? 复发性肾小球疾病手术:是第二次原发性手术还是再手术?
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2015.3112
Ahmet Deniz Uçar, Erdem Barış Cartı, Erkan Oymacı, Erdem Sarı, Savaş Yakan, Mehmet Yıldırım, Nazif Erkan

Objective: Pilonidal sinus disease (PSD) effects mainly young men's social and work life with frequent recurrence rate. Reoperation for unimproved or recurrent disease is somehow troublesome. Surgeons may think that changing treatment strategy after recurrence may prevent further relapses of PSD. We analyzed patients with recurrent pilonidal sinus to determine their predisposing features for recurrence and the outcomes of the preferred surgical methods.

Material and methods: From 2007 to 2012, out of 95 recurrent pilonidal sinus disease (rPSD) patients, 62 operated cases were included and examined retrospectively. Their retrospective data were examined for demographics, 1(st) and 2(nd) operation types, patient satisfaction and pain scores. For cases with insufficient preoperative or postoperative data, phone call and interviews were done to obtain data. Some were kindly invited to the outpatient examination. Student's t test, Mann-Whitney U test, and Kaplan Meier test for disease free survival time were used where appropriate. P values less than 0.05 were accepted to be statistically significant.

Results: Total of 62 rPSD patients were examined. Male:female ratio was 2.9:1. The mean age after 1(st) and 2(nd) operations were 24.7 and 28.1 years, respectively. One and five-year recurrence rates were 33.9% and 66.1%, respectively. The mean interval between the 1(st) and 2(nd) operations was 45.6 months. Excision and midline closure was the most frequent type of operation followed by flap reconstructions and excision-lay open procedures. The 1(st) operation types of rPSD cases were different from that of 2(nd) operations. Pain perception and satisfaction scores were better in flap reconstruction groups.

Conclusion: Reoperative surgery of rPSD is satisfactory with certain precautions. Relapses after flap reconstruction procedures with a well-being period should be referred as second primary disease. Changing surgical strategy is not always indicated as some patients with recurrence have relapsing or second primary disease that have distinct clinical course. Re-flap surgery after any kind of relapse is well appreciated.

目的:毛窦病(PSD)主要影响年轻男性的社会和工作生活,复发率高。对于未改善或复发的疾病,再手术有些麻烦。外科医生可能认为在复发后改变治疗策略可以防止PSD的进一步复发。我们分析了复发性毛突窦患者,以确定其复发的易感特征和首选手术方法的结果。材料与方法:回顾性分析2007 ~ 2012年95例复发性毛突窦病(rPSD)患者62例。对他们的回顾性资料进行人口统计学、1(1)和2(2)手术类型、患者满意度和疼痛评分的检查。对于术前或术后资料不足的病例,通过电话和访谈获取资料。一些人被邀请参加门诊检查。适当时采用学生t检验、Mann-Whitney U检验和Kaplan Meier无病生存时间检验。P值小于0.05被认为具有统计学意义。结果:共检查了62例rPSD患者。男女比例为2.9:1。第1次和第2次手术后的平均年龄分别为24.7岁和28.1岁。1年和5年复发率分别为33.9%和66.1%。第1次和第2次手术的平均间隔为45.6个月。切除和中线闭合是最常见的手术类型,其次是皮瓣重建和切除-开放手术。rPSD病例的第1(1)次手术类型与第2(2)次手术类型不同。皮瓣重建组疼痛感知和满意度得分较高。结论:经注意事项后,再手术效果满意。皮瓣重建手术后有一段健康期的复发应被视为第二原发疾病。改变手术策略并不总是意味着一些复发的患者有复发或第二原发疾病,有不同的临床过程。任何复发后的再皮瓣手术都是值得赞赏的。
{"title":"Recurrent pilonidal disease surgery: Is it second primary or reoperative surgery?","authors":"Ahmet Deniz Uçar,&nbsp;Erdem Barış Cartı,&nbsp;Erkan Oymacı,&nbsp;Erdem Sarı,&nbsp;Savaş Yakan,&nbsp;Mehmet Yıldırım,&nbsp;Nazif Erkan","doi":"10.5152/UCD.2015.3112","DOIUrl":"https://doi.org/10.5152/UCD.2015.3112","url":null,"abstract":"<p><strong>Objective: </strong>Pilonidal sinus disease (PSD) effects mainly young men's social and work life with frequent recurrence rate. Reoperation for unimproved or recurrent disease is somehow troublesome. Surgeons may think that changing treatment strategy after recurrence may prevent further relapses of PSD. We analyzed patients with recurrent pilonidal sinus to determine their predisposing features for recurrence and the outcomes of the preferred surgical methods.</p><p><strong>Material and methods: </strong>From 2007 to 2012, out of 95 recurrent pilonidal sinus disease (rPSD) patients, 62 operated cases were included and examined retrospectively. Their retrospective data were examined for demographics, 1(st) and 2(nd) operation types, patient satisfaction and pain scores. For cases with insufficient preoperative or postoperative data, phone call and interviews were done to obtain data. Some were kindly invited to the outpatient examination. Student's t test, Mann-Whitney U test, and Kaplan Meier test for disease free survival time were used where appropriate. P values less than 0.05 were accepted to be statistically significant.</p><p><strong>Results: </strong>Total of 62 rPSD patients were examined. Male:female ratio was 2.9:1. The mean age after 1(st) and 2(nd) operations were 24.7 and 28.1 years, respectively. One and five-year recurrence rates were 33.9% and 66.1%, respectively. The mean interval between the 1(st) and 2(nd) operations was 45.6 months. Excision and midline closure was the most frequent type of operation followed by flap reconstructions and excision-lay open procedures. The 1(st) operation types of rPSD cases were different from that of 2(nd) operations. Pain perception and satisfaction scores were better in flap reconstruction groups.</p><p><strong>Conclusion: </strong>Reoperative surgery of rPSD is satisfactory with certain precautions. Relapses after flap reconstruction procedures with a well-being period should be referred as second primary disease. Changing surgical strategy is not always indicated as some patients with recurrence have relapsing or second primary disease that have distinct clinical course. Re-flap surgery after any kind of relapse is well appreciated.</p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"162-7"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970772/pdf/ucd-32-3-162.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34310753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Re: Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging. 腋窝淋巴结细针穿刺活检对乳腺癌术前分期的预测价值。
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2016.25072016
Can Atalay
Axillary management in breast cancer has evolved tremendously in the last decades. Sentinel lymph node biopsy (SLNB) has replaced axillary dissection in patients without any clinical and radiological involvement in the axilla. Although the complication rate of SLNB is lower than axillary dissection, the search for an accurate method to determine the axillary status in breast cancer with even lower complication rate is continuing. Fine needle aspiration biopsy (FNAB) is performed under ultrasonography guidance in case of suspicious lymph nodes in the axilla, especially in those with cortical thickening or decreased echogenecity in the hilum in addition to changes in size and shape of the lymph node. The accuracy of FNAB in predicting the status of the axilla is investigated in recent studies. Fine needle aspiration biopsy of the axilla helps the clinician in determining surgical approach and neoadjuvant chemotherapy. Nowadays, extent of axillary surgery has almost no definitive role in deciding the mode of adjuvant treatment. Obtaining information about the presence of metastatic disease in the axilla is enough to determine the prognosis of the patient. However, 30% of axillary metastases were detected with FNAB under ultrasonography guidance and additional 30% with SLNB whereas the axillary status of the remaining patients were determined by histopathologic examination (1). In addition to the information about the axilla, FNAB enables us to place clips into the metastatic lymph nodes to follow the results of neoadjuvant treatment. Akinci et al. investigated this topic in the article entitled “Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging” (2). This study aimed to determine the role of ultrasound-guided FNAB in axillary staging. Sensitivity, specificity, positive and negative predictive value, and accuracy of FNAB were studied. Sensitivity and negative predictive value showed moderate values (60%) whereas specificity and positive predictive values were 100%. Overall accuracy of axillary FNAB was reported as 76.1%. These results are in accordance with the results of the previous studies. Sensitivity of FNAB under ultrasound guidance changes between 45-95% and the specific ity is almost 100% (3, 4). Microbiopsies using larger needles and addition of immunohistochemical examination increase the sensitivity and presence of micrometastases in the lymph node contributes to the false negative results (5). Small number of patients included in the study may be its limitation, however, prospective design of the study supports the results with higher reliability. Finally, this study encourages the clinicians to utilize ultrasound-guided FNAB more frequently to avoid unnecessary SLNB in breast cancer. As a conclusion, randomized controlled trials including large enough number of patients are required to establish the value of FNAB in axillary staging of breast cancer. Sentinel node vs. observat
{"title":"Re: Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging.","authors":"Can Atalay","doi":"10.5152/UCD.2016.25072016","DOIUrl":"https://doi.org/10.5152/UCD.2016.25072016","url":null,"abstract":"Axillary management in breast cancer has evolved tremendously in the last decades. Sentinel lymph node biopsy (SLNB) has replaced axillary dissection in patients without any clinical and radiological involvement in the axilla. Although the complication rate of SLNB is lower than axillary dissection, the search for an accurate method to determine the axillary status in breast cancer with even lower complication rate is continuing. Fine needle aspiration biopsy (FNAB) is performed under ultrasonography guidance in case of suspicious lymph nodes in the axilla, especially in those with cortical thickening or decreased echogenecity in the hilum in addition to changes in size and shape of the lymph node. The accuracy of FNAB in predicting the status of the axilla is investigated in recent studies. Fine needle aspiration biopsy of the axilla helps the clinician in determining surgical approach and neoadjuvant chemotherapy. Nowadays, extent of axillary surgery has almost no definitive role in deciding the mode of adjuvant treatment. Obtaining information about the presence of metastatic disease in the axilla is enough to determine the prognosis of the patient. However, 30% of axillary metastases were detected with FNAB under ultrasonography guidance and additional 30% with SLNB whereas the axillary status of the remaining patients were determined by histopathologic examination (1). In addition to the information about the axilla, FNAB enables us to place clips into the metastatic lymph nodes to follow the results of neoadjuvant treatment. Akinci et al. investigated this topic in the article entitled “Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging” (2). This study aimed to determine the role of ultrasound-guided FNAB in axillary staging. Sensitivity, specificity, positive and negative predictive value, and accuracy of FNAB were studied. Sensitivity and negative predictive value showed moderate values (60%) whereas specificity and positive predictive values were 100%. Overall accuracy of axillary FNAB was reported as 76.1%. These results are in accordance with the results of the previous studies. Sensitivity of FNAB under ultrasound guidance changes between 45-95% and the specific ity is almost 100% (3, 4). Microbiopsies using larger needles and addition of immunohistochemical examination increase the sensitivity and presence of micrometastases in the lymph node contributes to the false negative results (5). Small number of patients included in the study may be its limitation, however, prospective design of the study supports the results with higher reliability. Finally, this study encourages the clinicians to utilize ultrasound-guided FNAB more frequently to avoid unnecessary SLNB in breast cancer. As a conclusion, randomized controlled trials including large enough number of patients are required to establish the value of FNAB in axillary staging of breast cancer. Sentinel node vs. observat","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"197-8"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970778/pdf/ucd-32-3-197.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34654536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model. 西妥昔单抗腹腔注射对大鼠结肠吻合及术后早期粘连形成的影响。
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2016.3250
Atilla Kurt, Hasan Karanlık, Sinan Soylu, İlker Özgür, Hilal Oğuz Soydinç, Derya Duranyıldız, Vakur Olgaç, Fatma Şen, Oktar Asoğlu

Objective: We aimed to evaluate the effect of intraperitoneal cetuximab administration on the healing of anastomosis and development of early adhesion formation in a rat model.

Materials and methods: Twenty-four female rats were used. A colon segment was resected and end-to-end anastomosis was performed. The rats were randomized into three groups after the performance of colonic anastomosis and received 10 mL of intraperitoneal solution including study drugs after closure of abdominal cavity: normal saline was administered to the normal saline group (n=8), cetuximab (400 mg/m(2)) was administered to the postoperative 1 group (n=8) 1 day after surgery, and cetuximab (400 mg/m(2)) was administered to the peroperative group (n=8) during surgery.

Results: The mean adhesion grade was 2.63±0.92, and 0.50±0.76 and 0.63±0.74 for control and test groups, respectively. Cetuximab reduced adhesion formation in test groups (p<0.05). When all groups were compared, it was found that vascular endothelial growth factor levels decreased significantly only in the abdomen (p<0.05). Hydroxyproline levels and anastomosis bursting pressure were examined, and a statistical difference was found between groups (hydroxyproline p<0.05, bursting pressure p<0.05). However, when postoperative 1 day group was compared with the control group, it was found that there was no difference between groups according to these parameters (p>0.05), but when peroperative group was compared with the control group a significant decrease was observed in both parameters. Histopathological healing score was also evaluated. No statistical difference between groups was found.

Conclusion: Twenty-four hours later from the operation, intraperitoneal cetuximab therapy may be a safe and feasible treatment for metastatic colorectal patients.

目的:探讨西妥昔单抗腹腔注射对大鼠吻合口愈合及早期粘连形成的影响。材料与方法:雌性大鼠24只。切除一段结肠,进行端到端吻合。大鼠在完成结肠吻合后随机分为三组,关闭腹腔后给予含研究药物的腹腔内溶液10 mL:生理盐水组给予生理盐水(n=8),术后1组(n=8)术后1天给予西妥昔单抗(400 mg/m(2)),手术组(n=8)术中给予西妥昔单抗(400 mg/m(2))。结果:对照组和试验组的平均粘附等级分别为2.63±0.92、0.50±0.76和0.63±0.74。西妥昔单抗降低了试验组的粘连形成(p0.05),但手术组与对照组比较,两项指标均显著降低。同时评估组织病理学愈合评分。各组间无统计学差异。结论:术后24小时腹腔注射西妥昔单抗是治疗转移性结直肠癌患者安全可行的方法。
{"title":"Effect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model.","authors":"Atilla Kurt,&nbsp;Hasan Karanlık,&nbsp;Sinan Soylu,&nbsp;İlker Özgür,&nbsp;Hilal Oğuz Soydinç,&nbsp;Derya Duranyıldız,&nbsp;Vakur Olgaç,&nbsp;Fatma Şen,&nbsp;Oktar Asoğlu","doi":"10.5152/UCD.2016.3250","DOIUrl":"https://doi.org/10.5152/UCD.2016.3250","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to evaluate the effect of intraperitoneal cetuximab administration on the healing of anastomosis and development of early adhesion formation in a rat model.</p><p><strong>Materials and methods: </strong>Twenty-four female rats were used. A colon segment was resected and end-to-end anastomosis was performed. The rats were randomized into three groups after the performance of colonic anastomosis and received 10 mL of intraperitoneal solution including study drugs after closure of abdominal cavity: normal saline was administered to the normal saline group (n=8), cetuximab (400 mg/m(2)) was administered to the postoperative 1 group (n=8) 1 day after surgery, and cetuximab (400 mg/m(2)) was administered to the peroperative group (n=8) during surgery.</p><p><strong>Results: </strong>The mean adhesion grade was 2.63±0.92, and 0.50±0.76 and 0.63±0.74 for control and test groups, respectively. Cetuximab reduced adhesion formation in test groups (p<0.05). When all groups were compared, it was found that vascular endothelial growth factor levels decreased significantly only in the abdomen (p<0.05). Hydroxyproline levels and anastomosis bursting pressure were examined, and a statistical difference was found between groups (hydroxyproline p<0.05, bursting pressure p<0.05). However, when postoperative 1 day group was compared with the control group, it was found that there was no difference between groups according to these parameters (p>0.05), but when peroperative group was compared with the control group a significant decrease was observed in both parameters. Histopathological healing score was also evaluated. No statistical difference between groups was found.</p><p><strong>Conclusion: </strong>Twenty-four hours later from the operation, intraperitoneal cetuximab therapy may be a safe and feasible treatment for metastatic colorectal patients.</p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"157-61"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970771/pdf/ucd-32-3-157.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34310752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Local bupivacaine for postoperative pain management in thyroidectomized patients: A prospective and controlled clinical study. 局部布比卡因治疗甲状腺切除术患者术后疼痛:一项前瞻性对照临床研究。
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2015.3138
Ersin Gürkan Dumlu, Mehmet Tokaç, Haydar Öcal, Doğukan Durak, Halil Kara, Mehmet Kılıç, Abdussamed Yalçın

Objective: We aimed to evaluate the effect of bupivacaine and to compare the routes of administration of bupivacaine in the management of postoperative incision site pain after thyroidectomy.

Material and methods: Consecutive patients who were planned for thyroidectomy surgery were randomized into three groups of 30 patients each: Group 1 (control group): standard thyroidectomy surgery without additional intervention; Group 2 (paratracheal infiltration with bupivacaine): following thyroidectomy, 0.25% bupivacaine was applied on the surgical area; Group 3 (subcutaneous infiltration with bupivacaine): following thyroidectomy, 0.25% bupivacaine was injected into the cutaneous, subcutaneous region and fascia of the surgical area. Postoperative pain was evaluated by a visual analog scale (VAS) at 1(st), 4(th), and 12(th) hours after thyroidectomy. Total daily requirement for additional analgesia was recorded.

Results: The mean age of 90 patients was 44.37±13.42 years, and the female:male ratio was 62:28. There was no difference between study groups in terms of age, thyroid volume, TSH and T4 levels. VAS score of patients in paratracheal infiltration with bupivacaine group was significantly lower than control group patients at 1(st), 4(th) and 12(th) hours following thyroidectomy (p=0.030, p=0.033, p=0.039, respectively). The need for analgesics was significantly lower in both paratracheal infiltration and subcutaneous infiltration groups than the control group (86.7%, 83.0%, and 73.3%, respectively, p=0.049).

Conclusions: Intraoperative local bupivacaine application is effective in decreasing postoperative pain in patients with thyroidectomy.

目的:评价布比卡因治疗甲状腺切除术后切口疼痛的效果,比较布比卡因的给药途径。材料与方法:将拟行甲状腺切除术的连续患者随机分为三组,每组30例:第一组(对照组):标准甲状腺切除术,不加干预;2组(气管旁布比卡因浸润):甲状腺切除术后,0.25%布比卡因涂抹于手术区;第三组(布比卡因皮下浸润):甲状腺切除术后,在手术区皮肤、皮下和筋膜内注射0.25%的布比卡因。术后疼痛在甲状腺切除术后1(st)、4(th)和12(th)小时通过视觉模拟评分(VAS)进行评估。记录每日额外镇痛的总需求量。结果:90例患者平均年龄44.37±13.42岁,男女比例为62:28。在年龄、甲状腺体积、TSH和T4水平方面,研究组之间没有差异。布比卡因气管旁浸润组患者在甲状腺切除术后1(st)、4(th)、12(th) h的VAS评分显著低于对照组(p=0.030、p=0.033、p=0.039)。气管旁浸润组和皮下浸润组镇痛药需求均显著低于对照组(分别为86.7%、83.0%和73.3%,p=0.049)。结论:术中局部应用布比卡因可有效减轻甲状腺切除术患者术后疼痛。
{"title":"Local bupivacaine for postoperative pain management in thyroidectomized patients: A prospective and controlled clinical study.","authors":"Ersin Gürkan Dumlu,&nbsp;Mehmet Tokaç,&nbsp;Haydar Öcal,&nbsp;Doğukan Durak,&nbsp;Halil Kara,&nbsp;Mehmet Kılıç,&nbsp;Abdussamed Yalçın","doi":"10.5152/UCD.2015.3138","DOIUrl":"https://doi.org/10.5152/UCD.2015.3138","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to evaluate the effect of bupivacaine and to compare the routes of administration of bupivacaine in the management of postoperative incision site pain after thyroidectomy.</p><p><strong>Material and methods: </strong>Consecutive patients who were planned for thyroidectomy surgery were randomized into three groups of 30 patients each: Group 1 (control group): standard thyroidectomy surgery without additional intervention; Group 2 (paratracheal infiltration with bupivacaine): following thyroidectomy, 0.25% bupivacaine was applied on the surgical area; Group 3 (subcutaneous infiltration with bupivacaine): following thyroidectomy, 0.25% bupivacaine was injected into the cutaneous, subcutaneous region and fascia of the surgical area. Postoperative pain was evaluated by a visual analog scale (VAS) at 1(st), 4(th), and 12(th) hours after thyroidectomy. Total daily requirement for additional analgesia was recorded.</p><p><strong>Results: </strong>The mean age of 90 patients was 44.37±13.42 years, and the female:male ratio was 62:28. There was no difference between study groups in terms of age, thyroid volume, TSH and T4 levels. VAS score of patients in paratracheal infiltration with bupivacaine group was significantly lower than control group patients at 1(st), 4(th) and 12(th) hours following thyroidectomy (p=0.030, p=0.033, p=0.039, respectively). The need for analgesics was significantly lower in both paratracheal infiltration and subcutaneous infiltration groups than the control group (86.7%, 83.0%, and 73.3%, respectively, p=0.049).</p><p><strong>Conclusions: </strong>Intraoperative local bupivacaine application is effective in decreasing postoperative pain in patients with thyroidectomy.</p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"173-7"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970774/pdf/ucd-32-3-173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34654534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Effects of preoperative nutritional support on colonic anastomotic healing in malnourished rats. 术前营养支持对营养不良大鼠结肠吻合口愈合的影响。
Pub Date : 2015-09-01 eCollection Date: 2015-01-01 DOI: 10.5152/UCD.2015.3077
Rıza Haldun Gündoğdu, Uğur Yaşar, Pamir Eren Ersoy, Emre Ergül, Semra Işıkoğlu, Atilla Erhan

Objective: It has been proven that malnutrition increases postoperative morbidity and mortality, and it may also negatively affect wound healing in the gastrointestinal tract. In the literature, there is only one study evaluating the effects of preoperative nutritional support on colonic anastomotic healing under malnourished conditions. In order to improve the data on this topic, an experimental study was planned to evaluate the effects of preoperative nutritional support on colonic anastomotic healing in malnourished rats.

Material and methods: The study included 18 male Wistar albino rats divided into 3 groups. The control (C) group was fed ad libitum for 21 days. The malnutrition (M) group and preoperative nutrition (P) group were given 50% of the daily food consumed by the rats in Group C for 21 days to induce malnutrition. At the end of 21 days, Group P was fed ad libitum for 7 days (preoperative nutritional support). Colonic transection and end-to-end anastomosis was performed at 21 days in Group C and Group M and at 28 days in Group P. The rats were sacrificed at postoperative 4 days, anastomotic bursting pressure was measured, and samples were taken to analyze tissue hydroxyproline levels.

Results: Anastomotic bursting pressure was significantly higher in Group C than in Group M and Group P (p<0.05), and it was significantly higher in Group P than in Group M (p<0.05). Tissue hydroxyproline levels in Group P were found to be significantly higher than those in Group M and Group C (p<0.05).

Conclusion: One week of preoperative nutritional support increases collagen synthesis in the colon and positively affects anastomotic healing under malnourished conditions.

目的:已证实营养不良会增加术后发病率和死亡率,并可能对胃肠道伤口愈合产生负面影响。在文献中,只有一项研究评估了营养不良情况下术前营养支持对结肠吻合口愈合的影响。为了完善这方面的数据,我们计划进行一项实验研究,评估术前营养支持对营养不良大鼠结肠吻合口愈合的影响。材料与方法:选取雄性Wistar白化大鼠18只,分为3组。对照(C)组自由饲喂21 d。营养不良(M)组和术前营养(P)组给予C组大鼠日摄食量的50%诱导营养不良21 d。21 d时,P组自由饲喂7 d(术前营养支持)。C组和M组分别于21天和28天进行结肠横断端到端吻合,p组于术后4天处死大鼠,测定吻合口破裂压力,并取标本分析组织羟脯氨酸水平。结果:C组吻合口破裂压力明显高于M组和P组(P)。结论:术前1周营养支持可促进结肠胶原合成,对营养不良情况下吻合口愈合有积极影响。
{"title":"Effects of preoperative nutritional support on colonic anastomotic healing in malnourished rats.","authors":"Rıza Haldun Gündoğdu,&nbsp;Uğur Yaşar,&nbsp;Pamir Eren Ersoy,&nbsp;Emre Ergül,&nbsp;Semra Işıkoğlu,&nbsp;Atilla Erhan","doi":"10.5152/UCD.2015.3077","DOIUrl":"https://doi.org/10.5152/UCD.2015.3077","url":null,"abstract":"<p><strong>Objective: </strong>It has been proven that malnutrition increases postoperative morbidity and mortality, and it may also negatively affect wound healing in the gastrointestinal tract. In the literature, there is only one study evaluating the effects of preoperative nutritional support on colonic anastomotic healing under malnourished conditions. In order to improve the data on this topic, an experimental study was planned to evaluate the effects of preoperative nutritional support on colonic anastomotic healing in malnourished rats.</p><p><strong>Material and methods: </strong>The study included 18 male Wistar albino rats divided into 3 groups. The control (C) group was fed ad libitum for 21 days. The malnutrition (M) group and preoperative nutrition (P) group were given 50% of the daily food consumed by the rats in Group C for 21 days to induce malnutrition. At the end of 21 days, Group P was fed ad libitum for 7 days (preoperative nutritional support). Colonic transection and end-to-end anastomosis was performed at 21 days in Group C and Group M and at 28 days in Group P. The rats were sacrificed at postoperative 4 days, anastomotic bursting pressure was measured, and samples were taken to analyze tissue hydroxyproline levels.</p><p><strong>Results: </strong>Anastomotic bursting pressure was significantly higher in Group C than in Group M and Group P (p<0.05), and it was significantly higher in Group P than in Group M (p<0.05). Tissue hydroxyproline levels in Group P were found to be significantly higher than those in Group M and Group C (p<0.05).</p><p><strong>Conclusion: </strong>One week of preoperative nutritional support increases collagen synthesis in the colon and positively affects anastomotic healing under malnourished conditions.</p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"31 3","pages":"113-7"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605104/pdf/ucd-31-3-113.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34187140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
What has changed in the clinical presentation of breast carcinoma in 15 years? 15年来乳腺癌的临床表现发生了什么变化?
Pub Date : 2015-09-01 eCollection Date: 2015-01-01 DOI: 10.5152/UCD.2015.2951
Hüsnü Hakan Mersin, Volkan Kınaş, Kaptan Gülben, Fikret İrkin, Uğur Berberoğlu

Objective: The aim of this study is to investigate if there was a change in time in terms of age at diagnosis, menopausal status, pathologic tumor size, lymphatic metastasis and pathologic stage in patients with surgical treatment for breast carcinoma.

Material and methods: The clinical and pathological characteristics of 1223 patients with breast carcinoma who underwent surgical treatment between January 1994 and December 1998, and of 1346 patients who underwent surgical treatment with the same diagnosis between January 2004 and December 2008 were retrospectively reviewed.

Results: The median age at diagnosis was 48 (20-78) years during the first period, and 50 (20-91) years during the second period. While 27% of patients were 40 years of age or younger in the first period, this ratio decreased to 20% during the second period (p=0.0001). The rate of premenopausal patients was 54% in the first period and 46% in the second period (p=0.0001). The median tumor size at diagnosis was 3 cm at the first period, and 2.5 cm at the second period. The number of patients with tumor size ≤2 cm increased in time from 391 (32%) to 531 (39%) (p=0.0001). Among young patients (aged ≤40 years), the number of patients with tumor size 2 cm or smaller were 81 (24.5%) and 92 (33.8%) at the first and second periods, respectively (p=0.001). Lymphatic metastases rate of patients aged ≤40 years was higher than patients aged >40 years, in both study periods (p=0.0001). The number of patients staged as pN1 at the first period increased from 356 (50.8%) to 441 (56.3%) at the second interval, while those staged as pN3 decreased from 251 (35.8%) to 175 (22.3%) (p=0.0001).

Conclusion: It may be concluded that recently, breast cancer is diagnosed at older ages, the rate of young and premenopausal patients and size on diagnosis has decreased, and breast-conserving surgery is used more often.

目的:探讨乳腺癌手术治疗患者在诊断年龄、绝经期、肿瘤病理大小、淋巴转移及病理分期等方面是否存在时间上的变化。材料与方法:回顾性分析1994年1月至1998年12月手术治疗的1223例乳腺癌患者和2004年1月至2008年12月手术治疗的1346例相同诊断的乳腺癌患者的临床及病理特点。结果:第一期患者中位诊断年龄为48(20-78)岁,第二期患者中位诊断年龄为50(20-91)岁。在第一阶段,27%的患者年龄在40岁或以下,而在第二阶段,这一比例下降到20% (p=0.0001)。绝经前患者比例在第一期为54%,第二期为46% (p=0.0001)。第一期诊断时肿瘤中位大小为3cm,第二期为2.5 cm。肿瘤大小≤2 cm的患者从391例(32%)增加到531例(39%)(p=0.0001)。在年轻患者(年龄≤40岁)中,第一期和第二期肿瘤大小为2 cm及以下的患者分别为81例(24.5%)和92例(33.8%)(p=0.001)。在两个研究期间,年龄≤40岁的患者淋巴转移率均高于年龄>40岁的患者(p=0.0001)。第一期pN1患者从356例(50.8%)增加到441例(56.3%),第二期pN3患者从251例(35.8%)减少到175例(22.3%)(p=0.0001)。结论:近年来,乳腺癌的诊断年龄越来越大,年轻和绝经前患者的比例和诊断时的大小都有所下降,保乳手术的应用越来越多。
{"title":"What has changed in the clinical presentation of breast carcinoma in 15 years?","authors":"Hüsnü Hakan Mersin,&nbsp;Volkan Kınaş,&nbsp;Kaptan Gülben,&nbsp;Fikret İrkin,&nbsp;Uğur Berberoğlu","doi":"10.5152/UCD.2015.2951","DOIUrl":"https://doi.org/10.5152/UCD.2015.2951","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to investigate if there was a change in time in terms of age at diagnosis, menopausal status, pathologic tumor size, lymphatic metastasis and pathologic stage in patients with surgical treatment for breast carcinoma.</p><p><strong>Material and methods: </strong>The clinical and pathological characteristics of 1223 patients with breast carcinoma who underwent surgical treatment between January 1994 and December 1998, and of 1346 patients who underwent surgical treatment with the same diagnosis between January 2004 and December 2008 were retrospectively reviewed.</p><p><strong>Results: </strong>The median age at diagnosis was 48 (20-78) years during the first period, and 50 (20-91) years during the second period. While 27% of patients were 40 years of age or younger in the first period, this ratio decreased to 20% during the second period (p=0.0001). The rate of premenopausal patients was 54% in the first period and 46% in the second period (p=0.0001). The median tumor size at diagnosis was 3 cm at the first period, and 2.5 cm at the second period. The number of patients with tumor size ≤2 cm increased in time from 391 (32%) to 531 (39%) (p=0.0001). Among young patients (aged ≤40 years), the number of patients with tumor size 2 cm or smaller were 81 (24.5%) and 92 (33.8%) at the first and second periods, respectively (p=0.001). Lymphatic metastases rate of patients aged ≤40 years was higher than patients aged >40 years, in both study periods (p=0.0001). The number of patients staged as pN1 at the first period increased from 356 (50.8%) to 441 (56.3%) at the second interval, while those staged as pN3 decreased from 251 (35.8%) to 175 (22.3%) (p=0.0001).</p><p><strong>Conclusion: </strong>It may be concluded that recently, breast cancer is diagnosed at older ages, the rate of young and premenopausal patients and size on diagnosis has decreased, and breast-conserving surgery is used more often.</p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"31 3","pages":"148-51"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5152/UCD.2015.2951","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34118746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus. 锂相关原发性甲状旁腺功能亢进并发肾源性尿崩症。
Pub Date : 2015-09-01 eCollection Date: 2015-01-01 DOI: 10.5152/UCD.2014.2859
Nihat Aksakal, Candaş Erçetin, Beyza Özçınar, Ferihan Aral, Yeşim Erbil

Lithium-associated hyperparathyroidism is the leading cause of hypercalcemia in lithium-treated patients. Lithium may lead to exacerbation of pre-existing primary hyperparathyroidism or cause an increased set-point of calcium for parathyroid hormone suppression, leading to parathyroid hyperplasia. Lithium may cause renal tubular concentration defects directly by the development of nephrogenic diabetes insipidus or indirectly by the effects of hypercalcemia. In this study, we present a female patient on long-term lithium treatment who was evaluated for hypercalcemia. Preoperative imaging studies indicated parathyroid adenoma and multinodular goiter. Parathyroidectomy and thyroidectomy were planned. During the postoperative course, prolonged intubation was necessary because of agitation and delirium. During this period, polyuria, severe dehydration, and hypernatremia developed, which responded to controlled hypotonic fluid infusions and was unresponsive to parenteral desmopressin. A diagnosis of nephrogenic diabetes insipidus was apparent. A parathyroid adenoma and multifocal papillary thyroid cancer were detected on histopathological examination. It was thought that nephrogenic diabetes insipidus was masked by hypercalcemia preoperatively. A patient on lithium treatment should be carefully followed up during or after surgery to prevent life-threatening complications of previously unrecognized nephrogenic diabetes insipidus, and the possibility of renal concentrating defects on long-term lithium use should be sought, particularly in patients with impaired consciousness.

锂相关甲状旁腺功能亢进是锂治疗患者高钙血症的主要原因。锂可能导致原有原发性甲状旁腺功能亢进加重或导致抑制甲状旁腺激素的钙设定点升高,导致甲状旁腺增生。锂可通过肾源性尿崩症的发展直接引起肾小管浓度缺陷,或通过高钙血症的影响间接引起肾小管浓度缺陷。在这项研究中,我们提出了一位长期锂治疗的女性患者,她被评估为高钙血症。术前影像学检查显示甲状旁腺瘤和多结节性甲状腺肿。计划行甲状旁腺切除术和甲状腺切除术。在术后过程中,由于躁动和谵妄,需要延长插管时间。在此期间,出现多尿、严重脱水和高钠血症,对控制低渗液体输注有反应,而对静脉注射去氨加压素无反应。诊断为肾源性尿崩症。组织病理学检查发现甲状旁腺瘤和多灶性乳头状甲状腺癌。术前认为肾源性尿崩症被高钙血症所掩盖。接受锂治疗的患者在手术期间或手术后应仔细随访,以防止先前未发现的肾源性尿崩症并发症危及生命,并应寻求长期使用锂的肾脏集中缺陷的可能性,特别是在意识受损的患者中。
{"title":"Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus.","authors":"Nihat Aksakal,&nbsp;Candaş Erçetin,&nbsp;Beyza Özçınar,&nbsp;Ferihan Aral,&nbsp;Yeşim Erbil","doi":"10.5152/UCD.2014.2859","DOIUrl":"https://doi.org/10.5152/UCD.2014.2859","url":null,"abstract":"<p><p>Lithium-associated hyperparathyroidism is the leading cause of hypercalcemia in lithium-treated patients. Lithium may lead to exacerbation of pre-existing primary hyperparathyroidism or cause an increased set-point of calcium for parathyroid hormone suppression, leading to parathyroid hyperplasia. Lithium may cause renal tubular concentration defects directly by the development of nephrogenic diabetes insipidus or indirectly by the effects of hypercalcemia. In this study, we present a female patient on long-term lithium treatment who was evaluated for hypercalcemia. Preoperative imaging studies indicated parathyroid adenoma and multinodular goiter. Parathyroidectomy and thyroidectomy were planned. During the postoperative course, prolonged intubation was necessary because of agitation and delirium. During this period, polyuria, severe dehydration, and hypernatremia developed, which responded to controlled hypotonic fluid infusions and was unresponsive to parenteral desmopressin. A diagnosis of nephrogenic diabetes insipidus was apparent. A parathyroid adenoma and multifocal papillary thyroid cancer were detected on histopathological examination. It was thought that nephrogenic diabetes insipidus was masked by hypercalcemia preoperatively. A patient on lithium treatment should be carefully followed up during or after surgery to prevent life-threatening complications of previously unrecognized nephrogenic diabetes insipidus, and the possibility of renal concentrating defects on long-term lithium use should be sought, particularly in patients with impaired consciousness. </p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"31 3","pages":"166-9"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605114/pdf/ucd-31-3-166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34118750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
New developments in bariatric and metabolic surgery and HIPER-1 study. 减肥和代谢手术及HIPER-1研究的新进展。
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2016.3359
Alper Çelik
{"title":"New developments in bariatric and metabolic surgery and HIPER-1 study.","authors":"Alper Çelik","doi":"10.5152/UCD.2016.3359","DOIUrl":"https://doi.org/10.5152/UCD.2016.3359","url":null,"abstract":"","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"229-30"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970788/pdf/ucd-32-3-229.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34654544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fibroadenoma in the male breast: Truth or Myth? 男性乳房纤维腺瘤:真相还是神话?
Pub Date : 2015-09-01 eCollection Date: 2016-01-01 DOI: 10.5152/UCD.2015.3120
Puneet Agarwal, Gaurav Kohli

Truth or myth is seldom encountered in the practice of surgery, especially in cases of breast diseases. Yet, even after thousands of years of treating breast disease by surgeons/healers, fibroadenoma in the male breast seems to be a myth, due to the absence of fibro-glandular tissue. We wish to break this myth by our own experience as well as other studies by others all over the world, and unveil the truth that fibroadenoma in the male breast is a definitive entity and has a prevalence among the vast spectrum of breast diseases.

在外科手术实践中,真理或神话很少遇到,特别是在乳房疾病的情况下。然而,即使在外科医生/治疗师治疗乳腺疾病数千年之后,由于缺乏纤维腺组织,男性乳房中的纤维腺瘤似乎是一个神话。我们希望通过我们自己的经验以及世界各地其他人的其他研究来打破这个神话,并揭示男性乳房中的纤维腺瘤是一个明确的实体,并且在广泛的乳房疾病中普遍存在。
{"title":"Fibroadenoma in the male breast: Truth or Myth?","authors":"Puneet Agarwal,&nbsp;Gaurav Kohli","doi":"10.5152/UCD.2015.3120","DOIUrl":"https://doi.org/10.5152/UCD.2015.3120","url":null,"abstract":"<p><p>Truth or myth is seldom encountered in the practice of surgery, especially in cases of breast diseases. Yet, even after thousands of years of treating breast disease by surgeons/healers, fibroadenoma in the male breast seems to be a myth, due to the absence of fibro-glandular tissue. We wish to break this myth by our own experience as well as other studies by others all over the world, and unveil the truth that fibroadenoma in the male breast is a definitive entity and has a prevalence among the vast spectrum of breast diseases. </p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"32 3","pages":"208-11"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970781/pdf/ucd-32-3-208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34654538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Primary gastric tuberculosis mimicking gastric cancer. 类似胃癌的原发性胃结核。
Pub Date : 2015-09-01 eCollection Date: 2015-01-01 DOI: 10.5152/UCD.2014.2667
İsmail Cem Eray, Ahmet Rencüzoğulları, Orçun Yalav, Kubilay Dalcı, Erdem Kakil, Emine Bağır, Cem Kaan Parsak

A 42-year-old female patient with no previous known diseases who had complaints of postprandial epigastric pain and weight loss and who could not be diagnosed by endoscopic biopsy, although gastric cancer was suspected radiologically and endoscopically, was diagnosed with primary gastric tuberculosis by laparotomy and frozen section. Following anti-tuberculosis treatment, a complete clinical, radiological, and endoscopic response was achieved.

42岁女性患者,既往无已知疾病,主诉餐后胃脘痛、体重减轻,虽经影像学和内镜怀疑为胃癌,但内镜活检无法诊断,经开腹冰冻切片诊断为原发性胃结核。经过抗结核治疗后,取得了完整的临床、放射学和内窥镜反应。
{"title":"Primary gastric tuberculosis mimicking gastric cancer.","authors":"İsmail Cem Eray,&nbsp;Ahmet Rencüzoğulları,&nbsp;Orçun Yalav,&nbsp;Kubilay Dalcı,&nbsp;Erdem Kakil,&nbsp;Emine Bağır,&nbsp;Cem Kaan Parsak","doi":"10.5152/UCD.2014.2667","DOIUrl":"https://doi.org/10.5152/UCD.2014.2667","url":null,"abstract":"<p><p>A 42-year-old female patient with no previous known diseases who had complaints of postprandial epigastric pain and weight loss and who could not be diagnosed by endoscopic biopsy, although gastric cancer was suspected radiologically and endoscopically, was diagnosed with primary gastric tuberculosis by laparotomy and frozen section. Following anti-tuberculosis treatment, a complete clinical, radiological, and endoscopic response was achieved. </p>","PeriodicalId":90992,"journal":{"name":"Ulusal cerrahi dergisi","volume":"31 3","pages":"177-9"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605117/pdf/ucd-31-3-177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34120294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
期刊
Ulusal cerrahi dergisi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1